Otsuka Holdings
4578.T
#657
Rank
โ‚น3.834 T
Marketcap
โ‚น7,298
Share price
-0.37%
Change (1 day)
56.52%
Change (1 year)
Otsuka Pharmaceutical Co., Ltd. is a Japanese pharmaceutical company involved in the R&D of drugs and healing methods for respiratory diseases, eye diseases, cardiovascular diseases, neurological and mental diseases as well as Parkinson's, tuberculosis and cancer.

EPS for Otsuka Holdings (4578.T)

EPS in 2026 (TTM): โ‚น307.78

According to Otsuka Holdings 's latest financial reports the company's current EPS (TTM) is โ‚น336.52. In 2025 the company made an earnings per share (EPS) of โ‚น418.40 an increase over its 2024 EPS that were of โ‚น385.64.

EPS history for Otsuka Holdings from 2009 to 2026

Annual EPS

Year EPS Change
2026 (TTM)โ‚น307.78-26.44%
2025โ‚น418.408.5%
2024โ‚น385.64153.9%
2023โ‚น151.88-15.71%
2022โ‚น180.19-6.18%
2021โ‚น192.05-24.1%
2020โ‚น253.0422.95%
2019โ‚น205.8056.13%
2018โ‚น131.82-25.11%
2017โ‚น176.0225.99%
2016โ‚น139.72-6.37%
2015โ‚น149.23
2014N/A-100%
2013โ‚น224.8418.06%
2012โ‚น190.441.01%
2011โ‚น188.5329.07%
2010โ‚น146.07-94.47%
2009โ‚น2,641